Caspofungin (Cancidas) For Aspergillosis
Caspofungin acetate(Cancidas) is the first of a new class of antifungals, the echinocandins. It has been approved by the FDA for treatment of invasive aspergillosis in patients who fail to respond to or are unable to tolerate other antifungal drugs such as amphotericin B and itraconazole....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Caspofungin (Cancidas) For Aspergillosis
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1108
Article Code: 1108b
Date: July 9, 2001
Volume: 43
Pages: 58-59
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1108
Article Code: 1108b
Date: July 9, 2001
Volume: 43
Pages: 58-59
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)